Polyvalency: a promising strategy for drug design

Biotechnology and Bioengineering
David VanceRavi S Kane

Abstract

The simultaneous binding of multiple ligands on one entity to multiple receptors on another can result in an affinity that is significantly greater than that for the binding of a single ligand to a single receptor. This concept of "polyvalency" can be used to design molecules that are potent inhibitors of toxins and pathogens. We describe the design of potent polyvalent inhibitors that neutralize anthrax toxin in vivo as well as our attempts to elucidate the relationship between inhibitor structure and activity. We also highlight promising future avenues for research in polyvalent drug design.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Jun 5, 1997·Nature·K Simons, E Ikonen
Jun 1, 1997·Nature Biotechnology·E T Boder, K D Wittrup
Mar 24, 1998·Nature·E J GordonL L Kiessling
Jan 19, 1999·Annual Review of Cell and Developmental Biology·D A Brown, E London
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Oct 16, 1999·Proceedings of the National Academy of Sciences of the United States of America·A J GolumbfskieA K Chakraborty
Oct 3, 2001·Nature Biotechnology·M MourezR J Collier
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kristina CunninghamR John Collier
Jan 16, 2003·Biochemical Pharmacology·Kenneth A Bradley, John A T Young
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Dec 16, 2003·Angewandte Chemie·Wolfgang H BinderFredric M Menger
Mar 26, 2004·Nature Reviews. Drug Discovery·Mark R PrausnitzRobert Langer
Nov 27, 2004·Organic & Biomolecular Chemistry·Alart MulderDavid N Reinhoudt
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Sep 21, 2005·Accounts of Chemical Research·Jovica D BadjićJ Fraser Stoddart
Feb 28, 2006·Nature Medicine·John D LewisHeidi Stuhlmann
Mar 25, 2006·Angewandte Chemie·Laura L KiesslingLaura E Strong
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Saleem BashaRavi S Kane
Sep 21, 2006·Bioconjugate Chemistry·Amit JoshiRavi S Kane
Nov 25, 2006·Advanced Drug Delivery Reviews·Anna SergeevaWadih Arap
Mar 1, 2007·Nature Methods·Christian ZahndAndreas Plückthun
Sep 1, 2007·Science·Kristi L Kiick
Feb 20, 2008·Biochemistry. Biokhimii︠a︡·A V Kulbachinskiy
Mar 14, 2008·Combinatorial Chemistry & High Throughput Screening·Lauren R PepperEric V Shusta

❮ Previous
Next ❯

Citations

Oct 13, 2012·Chemical Reviews·Ekaterina M Nestorovich, Sergey M Bezrukov
Nov 18, 2011·Journal of the American Chemical Society·Eric T MackGeorge M Whitesides
Sep 8, 2012·Journal of Medicinal Chemistry·Alexander N WeinMichael Peredelchuk
Oct 22, 2013·Nature Nanotechnology·Anthony ConwayDavid V Schaffer
Jul 26, 2012·Molecular BioSystems·Wael R Abd-Elgaliel, Ching-Hsuan Tung
Aug 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Matthew J WebberSamuel I Stupp
May 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Quentin McAfeeRavi K Amaravadi
Aug 5, 2014·Chemical & Pharmaceutical Bulletin·Wipa TupchiangmaiYongsak Sritana-anant
Jan 23, 2014·Expert Opinion on Drug Discovery·Ekaterina M Nestorovich, Sergey M Bezrukov
Aug 2, 2012·Pharmacology & Therapeutics·Domenica Musumeci, Daniela Montesarchio
Dec 15, 2015·Pathogens and Disease·Sergey M Bezrukov, Ekaterina M Nestorovich
Jun 4, 2015·Molecular and Cellular Probes·Jun-Haeng ChoMoon-Young Yoon
Sep 29, 2011·Chemistry & Biology·Michael W HandlogtenBaşar Bilgiçer
Aug 19, 2017·Journal of Heterocyclic Chemistry·Ruben S VardanyanVictor J Hruby
Feb 13, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Michael B DeciJuliane Nguyen
Apr 20, 2019·Medicinal Research Reviews·Xiangyi JiangPeng Zhan
Jul 1, 2015·Beilstein Journal of Organic Chemistry·Susanne Liese, Roland R Netz
Jul 5, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna MakowskaŁukasz Balewski
Jun 24, 2014·Biomacromolecules·Philip FörstnerHolger Barth
Jan 15, 2014·Journal of the American Chemical Society·Daniela PonaderLaura Hartmann
Nov 27, 2014·Biomacromolecules·Chad T VarnerRavi S Kane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2022 Meta ULC. All rights reserved